Pharmacologic glycoengineering of Fcγ receptor IIIa enhances force-resistant IgG-FcγR interactions and anti-tumor antibody efficacy
- Journal:
- Immunity
- Published:
- Affiliations:
- 5
- Authors:
- 8
| Institutions | Authors | Share |
|---|---|---|
| Stanford University School of Medicine, United States of America (USA) | 0.50 | |
| University of Washington (UW), United States of America (USA) | 0.25 | |
| Weizmann Institute of Science (WIS), Israel | 0.25 |